ASCO Genitourinary Cancers Symposium approaches, several highly anticipated studies are set to shape the future of treatment ...

"The scale and scope of data to be presented at the ASCO GU meeting underscore the impact our whole-transcriptome-based Decipher tests are having in treating patients with urologic cancers, and how ...

Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

PIP and ADP are tax-free, non-means tested payments that do not affect the benefit cap, which means a single claimant over 25 on Universal Credit or JSA making a new claim for either benefit, could ...

Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune ...

New figures show women are presenting to emergency departments with preventable health issues, while highly trained primary health care nurses remain ...

Ampicillin is used to treat genitourinary tract infections, respiratory and ear ... This co-occurrence reduces treatment options by compromising the efficacy of first-line antibiotics commonly ...

(NYSE: PFE) will present the latest results from its leading genitourinary (GU ... diverse needs of patients across various stages of disease.” Pfizer’s GU portfolio includes seven approved ...